CHENGDU, China A company in China that manufactures modernized traditional Chinese medicine has appointed a new executive appointment.
Tianyin Pharmaceutical Co. announced Monday that it had appointed James Jiayuan Tong as CFO and chief business and development officer and had also appointed him to the board of directors. Tong will begin at Tianyin on Thursday.
“We are excited that Dr. Tong joins us as our chief financial officer and chief business and development officer,” Tianyin CEO Jiang Guoqing said in a statement.
Tong previously was head of Chinese healthcare investment banking at ROTH Capital Partners, based in Newport Beach, Calif. He earned his doctorate in neurobiology and behavior from Stony Brook University.